Switch Bioworks – Weekly Recap

Switch Bioworks, a biotechnology company developing biologically powered, low-cost sustainable fertilizer solutions, reported a pivotal week marked by leadership expansion, infrastructure growth, and heightened scientific visibility, signaling a transition from early-stage research toward scaled R&D and commercialization readiness. The company strengthened its executive team with three key C-suite hires: Steve del Cardayre as Chief Technology Officer, Brett Boghigian as Chief Business Officer, and climate-tech veteran Kaitlyn Qin as Chief Financial Officer. These appointments collectively enhance Switch Bioworks’ capabilities in product development, commercialization strategy, and financial and capital planning, supporting more disciplined execution as its biofertilizer platform enters scale-up.

To support its growing operations, Switch Bioworks relocated to a new headquarters in San Carlos, California, tripling its R&D footprint and consolidating fermentation, plant growth rooms, laboratories, and offices into a single facility. This expanded infrastructure is intended to increase experimental throughput, enable larger-scale trials, and improve coordination across scientific and business functions. The company also continued to build out its team, hiring Senior Research Associate Jose Zaragoza, whose prior experience at Ginkgo Bioworks and Bayer Cropscience strengthens its microbiology and agricultural R&D capabilities.

From a governance and risk-management perspective, Switch Bioworks appointed Liz Freeman Rosenzweig as Senior Counsel to oversee intellectual property, regulatory, legal, and government affairs, a move aimed at supporting a defensible IP portfolio and smoother regulatory engagement for its genetically engineered fertilizer products. Strategic and scientific guidance was further reinforced by the addition of agrifood industry veteran Eric Bartels as an advisor, while board member Doug Cameron and founding advisor Jennifer Cochran were elected to the National Academy of Engineering, enhancing the company’s external credibility.

On the scientific and industry engagement front, company leadership presented at the Microbiome AgBio Tech Summit and the European Nitrogen Fixation Conference, highlighting progress on microbial consortia and engineered genetic circuits for climate-focused, cost-effective biofertilizers. Internally, Switch Bioworks held an annual off-site focused on communication, strategic alignment, and team building, alongside ongoing hiring that signals continued investment in organizational capacity. Although no financial metrics or specific commercialization timelines were disclosed, the week’s developments collectively point to a company consolidating leadership, infrastructure, and technical foundations to support future field validation, partnerships, and eventual market entry in the ag-biologicals and climate-tech markets. Overall, it was a constructive week that strengthened Switch Bioworks’ positioning for its next phase of growth.